Kennedy Capital Management, Inc. Kezar Life Sciences, Inc. Transaction History

Kennedy Capital Management, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $6,234 - $14,561	1,992 Added 2.54%	80,328 $251,000
Q4 2022 Feb 14, 2023	SELL	$6.39 - $8.8 $600 - $827	-94 Reduced 0.12%	78,336 $551,000
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $71 - $96	9 Added 0.01%	78,430 $675,000
Q2 2022 Aug 10, 2022	SELL	$4.58 - $17.13 $1.33 Million - $4.98 Million	-290,914 Reduced 78.77%	78,421 $649,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $876,055 - $1.31 Million	-71,224 Reduced 16.17%	369,335 $6.14 Million
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $78,759 - $176,997	-10,586 Reduced 2.35%	440,559 $7.37 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $9.73 $37,553 - $75,339	-7,743 Reduced 1.69%	451,145 $3.9 Million
Q2 2021 Aug 16, 2021	SELL	$4.93 - $6.46 $249,758 - $327,270	-50,661 Reduced 9.94%	458,888 $2.49 Million
Q1 2021 May 14, 2021	SELL	$5.24 - $6.99 $99,670 - $132,956	-19,021 Reduced 3.6%	509,549 $3.04 Million
Q4 2020 Feb 12, 2021	SELL	$4.77 - $6.58 $11,648 - $16,068	-2,442 Reduced 0.46%	528,570 $2.76 Million
Q3 2020 Nov 16, 2020	BUY	$4.36 - $5.5 $1.27 Million - $1.6 Million	290,688 Added 120.96%	531,012 $2.57 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $865,166 - $1.86 Million	240,324 New	240,324 $1.25 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.